Standardization of flow cytometric detection of antigen expression
Cytometry Part B: Clinical Cytometry · 2024-01 · 106 (1) · 25-34
DOI: 10.1002/cyto.b.22155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytometry Part B: Clinical Cytometry, online erschienen am 12.01.2024. Verfasst von Linhua Tian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, Maryland, USA. Hauptthemen laut MEDLINE: Antibodies, Antigens. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIST DOC.
Abstract (Originalsprache)
Since response to antigen‐based immunotherapy relies upon the level of tumor antigen expression we developed an antigen quantification assay using ABC values. Antigen quantification as a clinical assay requires methods for quality control and for interlaboratory and inter‐cytometer platform standardization. A single lot of Cytotrol™ Lyophilized Control Cells (Beckman Coulter) used for all studies. The variability in antigen quantification across 4 different instrument platforms in 2 separate laboratories was evaluated. The effect of the antibody clone utilized, importance of custom 1:1 molar ratio (fluorophore to protein, F/P) verses off‐the‐shelf antibodies, and QuantiBrite PE calibration verses linearity calibration combined with a single point scale transformation with CD4 as reference were determined. Use of single lot control cells allowed validation of reproducibility between flow cytometer platforms and laboratories and allowed assessment of different antibody lots, cocktail preparation, and different antibody clones. Off the shelf antibody preparations provide reproducible estimates of antigen density, however custom 1:1 unimolar antibody preparations should be utilized for definitive measurement of antigen expression.Geometric Mean fluorescent Intensity (GeoMFI) was not comparable across instruments and inter‐laboratory. The use of CD4 as the reference marker can minimize variability in ABC values. Comparable antigen quantification is vital in managing patients receiving antigen‐based immunotherapy. If this assay is to be utilized in a clinical setting, quality control methods have to be instituted to assure reproducibility and allow validation across laboratories. We have demonstrated that use of a lyophilized cell control is highly valuable in achieveing these goals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biosystems and Biomaterials Division, National Institute of Standards and Technology (NIST), Gaithersburg, Maryland, USA.
- Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Constance Yuan, Hao-Wei Wang
Förderung
- Intramural NIST DOC
Zitieren
APA
Tian, L., Nelson, A. R., Lowe, T., Weaver, L., Yuan, C., Wang, H. W., DeRose, P., Stetler-Stevenson, M., & Wang, L. (2024). Standardization of flow cytometric detection of antigen expression. Cytometry Part B: Clinical Cytometry, 106(1), 25-34. https://doi.org/10.1002/cyto.b.22155
Vancouver
Tian L, Nelson AR, Lowe T, Weaver L, Yuan C, Wang HW, et al. Standardization of flow cytometric detection of antigen expression. Cytometry Part B: Clinical Cytometry. 2024;106(1):25-34. doi:10.1002/cyto.b.22155
BibTeX
@article{Tian2024,
author = {Tian, Linhua and Nelson, Aaron R and Lowe, Tyler and Weaver, Linda and Yuan, Constance and Wang, Hao-Wei and DeRose, Paul and Stetler-Stevenson, Maryalice and Wang, Lili},
title = {Standardization of flow cytometric detection of antigen expression},
journal = {Cytometry Part B: Clinical Cytometry},
year = {2024},
volume = {106},
number = {1},
pages = {25--34},
doi = {10.1002/cyto.b.22155}
}
EUVIMED